• Hermann Lehn, Ph.D., Vice President Non-Clinical Safety, Global, Head of QA GLP & Head of Tox/Path Outsourcing Europe, F.Hoffman-La Roche, Switzerland
• Isabella Andreini, DVM, PhD, Expert in Immunotoxicology, Research Technology Centre, RTC, Italy
• Deborah DiNoto, Global Director, Operations for Global Metabolism & PK, sanofi-aventis, USA
• Olivier Brun, Procurement Global Category Head Material & Subcontracting Scientific & Clinical Domain, sanofi-aventis R&D
• Stephen Porter, Owner, VDDI Pharmaceuticals, USA
• Tiina Pirttilä, Contract Manager, Research Scientist, Orion Pharma, Finland
• Paul Overton, Group Director, Corporate Development, HLS, UK